Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111205211B reveals a green solid-acid catalyzed route for high-purity 2,4-difluorophenylpyrrole, offering significant cost reduction and supply chain reliability for FMT manufacturing.
Patent CN111116466B reveals a low-cost ZnI2 catalyzed route for high-purity quinoline derivatives. Reduces catalyst cost by 3 orders of magnitude versus Rhodium.
Patent CN113620764A reveals a novel thiol oxidation route for sulfonyl thioesters. Achieve >99% purity without metal catalysts, ensuring cost-effective supply chain solutions.
Patent CN103193803A introduces a stable CuSeCF3 reagent synthesis, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Novel patent CN104628545B enables green synthesis of P-methoxybenzaldehyde with high purity. This method offers significant supply chain stability and cost reduction for pharmaceutical intermediate manufacturing.
Novel rare earth silamide catalyst enables high-yield indole production from indolinones, offering significant cost and supply chain advantages for global manufacturers.
Patent CN115974770B reveals high-purity nitroxide synthesis. Enhanced stability and cost-effective manufacturing for global polymer additive supply chains.
Patent CN101875640A reveals a green decarboxylation method for pyrazinecarboxylic acid using recyclable ionic liquids, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel metal-free route for high-purity triazole intermediates. Reduces cost and supply chain risk for pharma manufacturing.
Novel chiral phosphine amide ester catalyst enables high enantioselectivity in Henry reactions, offering scalable solutions for pharmaceutical intermediates.
Patent CN109678853B reveals a green one-pot dasatinib synthesis using ionic liquids, offering high purity and cost reduction for pharmaceutical manufacturing supply chains.
Patent CN113789310B reveals high-yield transaminase route for moxifloxacin intermediates, eliminating DMSO for cost-effective and scalable API manufacturing.
Patent CN120441503A reveals mild demethylation for Dotinurad. Achieve high purity and yield with reduced costs for reliable pharmaceutical manufacturing supply chains.
Patent CN110950793B details a metal-free, biphasic synthesis of chiral diarylindolemethanes with high stereoselectivity, offering cost-effective supply chain solutions.
Advanced synthesis of Propiconazole using solid heteropoly acid catalysis and one-pot condensation. Reduces waste and improves yield for agrochemical manufacturers.
Novel amide-type solanesol derivatives with antitumor activity. Efficient synthesis via mild coupling ensures high purity and cost-effective manufacturing for pharma applications.
Patent CN118852253B reveals metal-free visible light catalysis for high-purity heterocyclic compounds offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN111454222A details a metal-free, one-step synthesis of quinazoline diones using CO2, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN107417543B introduces a safe, solid-reagent method for brominating fused-ring aromatics, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN103360339A details a water-based ionic liquid method for synthesizing aminothiazole derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.